DRIVE PK: A Phase 2 Trial of AG-348 in Patients with Pyruvate Kinase Deficiency

被引:0
|
作者
Barbier, Ann [1 ]
Silver, Bruce [2 ]
Merica, Elizabeth [1 ]
Cohen, Marvin [3 ]
Kung, Charles [1 ]
Yang, Hua [1 ]
Grace, Rachael F. [4 ]
Glader, Bertil [5 ]
Agresta, Sam [1 ]
机构
[1] Agios Pharmaceut, Cambridge, MA USA
[2] Bruce A Silver Clin Sci & Dev, Dunkirk, MD USA
[3] MBC Pharma Solut, Newtown, PA USA
[4] Harvard Univ, Sch Med, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[5] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] 2 CASES OF PYRUVATE-KINASE DEFICIENCY - PK KAMAKURA AND PK NANIWA
    TAKEGAWA, S
    FUJII, H
    TAKAHASHI, K
    MORISAKI, T
    HIRONO, A
    TAKIZAWA, T
    KANNO, H
    TSUJINO, G
    MIWA, S
    ACTA HAEMATOLOGICA JAPONICA, 1985, 48 (06): : 1332 - 1336
  • [22] PYRUVATE-KINASE (PK) DEFICIENCY IN JORDAN
    KARADSHEH, NS
    HAEMATOLOGICA, 1993, 78 (02) : 80 - 83
  • [23] Targeting the red cell enzyme pyruvate kinase with a small allosteric molecule AG-348 may correct underlying pathology of a glycolytic enzymopathy
    Alayash, Abdu I.
    HAEMATOLOGICA, 2021, 106 (01) : 9 - 11
  • [24] Validation of the Pyruvate Kinase Deficiency Diary (PKDD): A PatientReported Outcome Measure for Pyruvate Kinase (PK) Deficiency
    Egan, Shayna
    Zagadailov, Erin
    Jewett, Adrian
    Li, Junlong
    Tai, Feng
    Boscoe, Audra
    Andrae, David A.
    BLOOD, 2021, 138
  • [25] Increased levels of pyruvate kinase (PK) antigen in red blood cells of patients with pk deficiency
    van Oirschot, Brigitte A.
    van Solinge, Wouter W.
    van Wijk, Richard
    CLINICAL BIOCHEMISTRY, 2009, 42 (18) : 1859 - 1859
  • [26] Phase I Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase-R, in Healthy Subjects
    Yang, Hua
    Merica, Elizabeth
    Chen, Yue
    Cohen, Marvin
    Goldwater, Ronald
    Hill, Collin
    Kim, Hyeryun
    Kosinski, Penelope
    Kung, Charles
    Silver, Bruce
    Utley, Luke
    Agresta, Sam
    BLOOD, 2014, 124 (21)
  • [27] METABOLIC VULNERABILITY OF RETICULOCYTES IN PYRUVATE KINASE (PK) DEFICIENCY
    MENTZER, WC
    BAEHNER, RL
    SCHMIDTS.H
    NATHAN, DG
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1969, 34 (06): : 861 - &
  • [28] Pyruvate kinase (PK) deficiency in newborns: The pitfalls of diagnosis
    Pissard, Serge
    De Montalembert, Mariane
    Bachir, Dora
    Max-Audit, Isabelle
    Goossens, Michel
    Wajcman, Henri
    Bader-Meunier, Brigitte
    JOURNAL OF PEDIATRICS, 2007, 150 (04): : 443 - 445
  • [29] TRANSIENT PYRUVATE-KINASE (PK) DEFICIENCY IN NEWBORNS
    VALAES, T
    TSOCHATZISYIANNOPOULOS, K
    KARAKLIS, A
    NECHELES, TF
    PEDIATRIC RESEARCH, 1975, 9 (04) : 327 - 327
  • [30] 2 HOMOZYGOUS CASES OF ERYTHROCYTE PYRUVATE-KINASE (PK) DEFICIENCY IN JAPAN - PK SENDAI AND PK SHINSHU
    TANI, K
    TSUTSUMI, H
    TAKAHASHI, K
    OGURA, H
    KANNO, H
    HAYASAKA, K
    NARISAWA, K
    NAKAHATA, T
    AKABANE, T
    MORISAKI, T
    FUJII, H
    MIWA, S
    AMERICAN JOURNAL OF HEMATOLOGY, 1988, 28 (03) : 186 - 190